AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Remiglim M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Remington Life Sciences LLP

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Remiglim M 2mg/500mg Tablet

Diabeva Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabeva Duo should be taken with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue this treatment even if feeling well or experiencing controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. Remember, it’s a component of a comprehensive plan including a balanced diet, regular physical activity, and weight management, as advised by your doctor. Lifestyle choices are crucial for diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms—sweating, dizziness, headache, tremors—and how to manage them. Regular meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are essential preventative measures. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; some patients may experience weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Disclose any history of heart disease to your doctor prior to use, as it may not be appropriate. Pregnant or breastfeeding individuals should seek medical advice before starting this treatment. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Remiglim M 2mg/500mg Tablet

The provided text is "undefined," which contains no information to rephrase. Therefore, no rewritten text can be provided.

Uses of Remiglim M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Remiglim M 2mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/500mg Remiglim M Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Remiglim M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Remiglim M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. The Remiglim M 2mg/500mg Tablet should be administered with a meal.

How Remiglim M 2mg/500mg Tablet works:

Remiglim M 2mg/500mg tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Remiglim M 2mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Remiglim M 2mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingUNSAFE

Lactation and Remiglim M 2mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Remiglim M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Remiglim M 2mg/500mg tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Remiglim M 2mg/500mg tablets cautiously, potentially requiring dose modification. Physician consultation is advised. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Remiglim M 2mg/500mg Tablet :

Should you forget to take your Remiglim M 2mg/500mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take a double dose.

Facts to Know About Remiglim M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Remiglim M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Remiglim M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Remiglim M 2mg/500mg Tablets and seek immediate medical attention.
Remiglim M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Remiglim M 2mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Remiglim M 2mg/500mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Remiglim M 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Remiglim M 2mg/500mg tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Remiglim M 2mg/500mg Tabl...
60
MRP 69
13% off